| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C16H21N3
|
|---|
| Exact mass |
255.1735
|
|---|
| Mol weight |
255.36
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04AA Antihistamines for topical use
D04AA04 Tripelennamine
D08645 Tripelennamine (INN)
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AC Substituted ethylene diamines
R06AC04 Tripelennamine
D08645 Tripelennamine (INN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG00383 Tripelennamine
D08645 Tripelennamine
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00383 Tripelennamine
D08645 Tripelennamine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D08645 Tripelennamine (INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08645
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8x C 5.6700 -11.7600
2 C8x C 5.6700 -13.1600
3 C8x C 6.8824 -13.8600
4 C8x C 8.0949 -13.1600
5 C8y C 8.0949 -11.7600
6 C8x C 6.8824 -11.0600
7 N5x N 9.3073 -13.8600
8 C8y C 10.5197 -13.1600
9 N1c N 10.5197 -11.7600
10 C1b C 9.3073 -11.0600
11 C8x C 9.3073 -15.2600
12 C8x C 10.5197 -15.9600
13 C8x C 11.7322 -15.2600
14 C8x C 11.7322 -13.8600
15 C1b C 11.7173 -11.0685
16 C1b C 12.9056 -11.7545
17 N1c N 14.0964 -11.0669
18 C1a C 15.2860 -11.7537
19 C1a C 14.0964 -9.6602
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 9 10 1
10 5 10 1
11 7 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 8 14 2
16 9 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 17 19 1
|
|---|
|
